Fluzoparib Plus Famitinib Maintenance After First-Line Platinum Response in Advanced Ovarian Cancer
Clinical trial NCT07382713 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07382713
- Sponsor
- Jinhua Zhou
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-02-28
- Primary completion
- 2030-12-31
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.